NTRA News and Press, Natera Inc. From 03/21/22

Natera Announces Updated Signatera™ MRD Data from CIRCULATE-Japan Presented in Plenary Talk at the Society of Surgical Oncology Conference, and Activation of CIRCULATE-US Trial PR Newswire Updated analysis shows 75% detection of recurrence with a single blood dr...

NEW YORK, NY / ACCESSWIRE / March 18, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Natera, Inc. ("Natera" or the "Company") (NASDAQ:NTRA). Investors who purchased Natera securities are encouraged to obtain additional information a...

Whether it's true or not, a short-seller report can often send shares of a stock plummeting in a hurry. That's what has happened to genetic testing company Natera (NASDAQ: NTRA) , which has fallen after a report criticizing its business made investors think twice about the stock. ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Natera To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 17, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...

Natera's (NTRA +8.8%) lead independent director of board of directors and partner at Sequoia Capital, Roelof Botha has invested $5M to purchase shares of the company on the open market. In addition, company executives and non-employee directors have elected to exchange the...

Roelof Botha, Lead Independent Director of Natera Board, Makes $5 Million Investment in Natera PR Newswire AUSTIN, Texas , March 16, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced that Roelof Botha , ...

Gainers: Incannex Healthcare IXHL +209%. Revelation Biosciences (NASDAQ:REVB) +25%. Co-Diagnostics CODX +14%. GreenLight Biosciences (NASDAQ:GRNA) +14%. Clearside Biomedical (NASDAQ:CLSD) +12%. Losers: Better Therapeutics BTTX -33%. ANI Pharmaceuticals ...

Boston, Massachusetts--(Newsfile Corp. - March 15, 2022) - Block & Leviton is investigating Natera, Inc. (NASDAQ: NTRA) for potential securities law violations. Investors who have lost money in their Natera, Inc. investment should contact the firm to learn more about how they might recov...

Jury Finds CareDx and Natera Engaged in False Advertising PR Newswire AUSTIN, Texas , March 15, 2022 /PRNewswire/ -- A jury in Delaware District Court found that both CareDx, Inc. and Natera, Inc. engaged in false advertising – including that Care...

SOUTH SAN FRANCISCO, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers...